Biotricity, الرعاية الصحية

Biotricity announces a strategic partnership for cardiac screenings in patients with co-morbidities

Biotricity Inc. (Biotricity) continues its strategic expansion with the announcement of its latest partnership in neurology to conduct cardiac screenings in patients suffering from neurological issues.  There are over 1,000 neurological disorders and over 100 million Americans suffering from at least 1 neurological issue. Alzheimer’s, Parkinsons, and other dementias are just a few such conditions that lead to increased cardiovascular risk. Many of these patients are screened late, leading to an increase in costs and higher patient risk. Biotricity is focused on providing earlier screenings to patients with co-morbidities, reducing costs while improving the quality of care.

Recent Comments

لا توجد تعليقات للعرض.
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
موقع YouTube
Consent to display content from - Youtube
فيميو
Consent to display content from - Vimeo
خرائط جوجل
Consent to display content from - Google
سبوتيفي
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound